# A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

> **NCT06097702** · PHASE1 · COMPLETED · sponsor: **Bilix Co.,Ltd.** · enrollment: 51 (actual)

## Conditions studied

- Ischemia-reperfusion Injury

## Interventions

- **DRUG:** BX-001N Part 1
- **DRUG:** BX-001N Part 2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06097702
- **Lead sponsor:** Bilix Co.,Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-17
- **Primary completion:** 2024-11-06
- **Final completion:** 2024-11-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097702, "A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06097702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*